Clofazimine-related duodenal pigmentation
- PMID: 33417175
- DOI: 10.1007/s12664-020-01128-6
Clofazimine-related duodenal pigmentation
References
-
- U.S. Leprosy Panel (U.S.-Japan Cooperative Medical Science Program). Leonard Wood Memorial Spaced clofazimine therapy of lepromatous leprosy. Am J Trop Med Hyg. 1976;25:437–44. - DOI
-
- Barry VC, Buggle K, Byrne J, Conalty ML, Winder F. Absorption, distribution and retention of the rimino compounds in the experimental animal. Ir J Med Sci. 1960;416:345–52. - DOI
-
- Geboes K, Hertogh GD, Ectors N. Drug-induced pathology in the large intestine. Curr Diagn Pathol. 2006;12:239–47. - DOI
-
- Szeto W, Garcia-Buitrago MT, Abbo L, Rosenblatt JD, Moshiree B, Morris MI. Clofazimine enteropathy: a rare and underrecognized complication of mycobacterial therapy. Open Forum Infect Dis. 2016;3:ofw004.
-
- Baik J, Stringer KA, Mane G, Rosania GR. Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration response. Antimicrob Agents Chemother. 2013;57:1218–30. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical